Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Chih Yang

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Plos One|December 22, 2018
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Journal of Virology|December 8, 2006
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressorsJoel N Blankson, Justin R Bailey, Seema Thayil, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 20, 2022
Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccineWang-Huei Sheng, Si-Man Ieong, Pin-Hung Lin, et al.
Journal of Gastroenterology and Hepatology|August 29, 2018
Profile and value of FIB-4 in patients with dual chronic hepatitis C and BChun-Jen Liu, Tai-Chung Tseng, Wan-Ting Yang, et al.
Plos One|September 11, 2012
Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathwayWei-Liang Liu, Hung-Chih Yang, Wen-Cheng Su, et al.
Journal of Clinical Microbiology|March 6, 2015
Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotypingChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 20, 2021
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agentsShang-Chin Huang, Pin-Nan Cheng, Chen-Hua Liu, et al.
Journal of Virology|March 25, 2011
Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell modelLiang Shan, Hung-Chih Yang, S Alireza Rabi, et al.
Gastroenterology|January 15, 2023
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen LevelsTai-Chung Tseng, Chieh Chiang, Chun-Jen Liu, et al.
Hepatology International|November 6, 2021
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelinesWei Teng, Ting-Tsung Chang, Hwai-I Yang, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Plos One|December 22, 2018
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Journal of Virology|December 8, 2006
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressorsJoel N Blankson, Justin R Bailey, Seema Thayil, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 20, 2022
Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccineWang-Huei Sheng, Si-Man Ieong, Pin-Hung Lin, et al.
Journal of Gastroenterology and Hepatology|August 29, 2018
Profile and value of FIB-4 in patients with dual chronic hepatitis C and BChun-Jen Liu, Tai-Chung Tseng, Wan-Ting Yang, et al.
Plos One|September 11, 2012
Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathwayWei-Liang Liu, Hung-Chih Yang, Wen-Cheng Su, et al.
Journal of Clinical Microbiology|March 6, 2015
Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotypingChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 20, 2021
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agentsShang-Chin Huang, Pin-Nan Cheng, Chen-Hua Liu, et al.
Journal of Virology|March 25, 2011
Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell modelLiang Shan, Hung-Chih Yang, S Alireza Rabi, et al.
Gastroenterology|January 15, 2023
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen LevelsTai-Chung Tseng, Chieh Chiang, Chun-Jen Liu, et al.
Hepatology International|November 6, 2021
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelinesWei Teng, Ting-Tsung Chang, Hwai-I Yang, et al.
Pageof 15